# Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants

> **NCT01441206** · PHASE1 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 2 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** rifampin

## Key facts

- **NCT ID:** NCT01441206
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study to be redesigned.
- **Last updated:** 2012-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441206, "Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01441206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*